Human Leukocyte Antigen Hla Testing Market Scope And Analysis

  • Report Code : TIPRE00021578
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 221
Buy Now

Human Leukocyte Antigen (HLA) Testing Market Analysis, Trends, and Scope 2022 to 2028

Buy Now

Human Leukocyte Antigen (HLA) Testing Market Report Human Leukocyte Antigen (HLA) Testing Market Size and Share Human Leukocyte Antigen (HLA) Testing Market Scope and Analysis

Human Leukocyte Antigen (HLA) Testing Market Report Scope

Report Attribute Details
Market size in 2021 US$ 697.74 Million
Market Size by 2028 US$ 1,155.65 Million
Global CAGR (2021 - 2028) 7.5%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product and Services
  • Reagents & Consumables
  • Instruments
  • Software & Services
By Technology
  • Molecular Assay Technologies
  • Non-Molecular Assay Technologies
By End User
  • Independent Reference Laboratories
  • Hospitals and Transplant Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Thermo Fisher Scientific Inc
  • CareDx
  • Qiagen
  • Illumina Inc
  • Bio Rad Laboratories Inc
  • TBG Diagnostics Limited
  • F Hoffmann La Roche Ltd
  • Takara Bio Inc
  • Luminex Corporation

    • Company Profiles

    • Thermo Fisher Scientific Inc.
    • CareDx
    • Qiagen
    • Illumina Inc.
    • Bio-Rad Laboratories, Inc.
    • TBG Diagnostics Limited
    • F.Hoffmann-La Roche Ltd.
    • Takara Bio Inc.
    • Luminex Corporation
    • Omixon Inc.
    • The Sequencing Center
    • Protrans
    • HistoGenetics LLC.
    • CD Genomics
    • Qunitara Biosciences
    • CeGat GmbH
    • Creative Biolabs Inc.